http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103074282-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_052a9db42e32a622fd7a5b606b68799e |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-01 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-103 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-00 |
| filingDate | 2013-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2014-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cfa4a6fd126fa69469331b87be8a96bf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1da9cf18deb499d98ba0035adce75f56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8eb1109597455205449a873ca9d4be31 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_77c0f5819a8e877007a8bee0f10c06c3 |
| publicationDate | 2014-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103074282-B |
| titleOfInvention | Tumor targeted bacterium and bactericide preparation method and metabolic product of tumor targeted bacterium |
| abstract | The invention discloses a tumor targeted bacterium and a bactericide preparation method and a metabolic product of the tumor targeted bacterium. The tumor targeted bacterium is Xenorhabdus stockiae HN-xs01 and is preserved in the China Center for Type Culture Collection (CCTCC) on March 9, 2012 with a preservation number of CCTCC NO: M2012069. The invention further relates to the bactericide preparation method and the metabolic product of the tumor targeted bacterium. The tumor targeted bacterium can specially accumulate at a tumor site of a mouse through intravenous injection, cannot be colonized in normal tissues and organs of the mouse, such as a liver, a kidney and a spleen, and has very high tumor targeting; an anti-tumor rate is 60-100% through a weight comparison among final tumors; and the tumor targeted bacterium has a very good in-vivo anti-tumor effect on a mouse melanin tumor. |
| priorityDate | 2013-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 133.